Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Psoriasis × Methotrexate × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Neoplasm, Residual 3 Arthritis, Rheumatoid 3 Subcutaneous panniculitis-like T-cell lymphoma 1 Psoriasis 1 Mycosis Fungoides 1 Medulloblastoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Biphenotypic, Acute 1 Immunoblastic Lymphadenopathy 1 Enteropathy-Associated T-Cell Lymphoma 1 Burkitt Lymphoma 1

Interventions

secukinumab 1 Methotrexate 1 Folic Acid 1 Etanercept 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00932113 2017-08-31

MOA

Tufts Medical Center

Phase 4 Completed

33 enrolled 11 charts

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡